Opal Joshi is a Director at Leerink Partners, based in the United States. She assumed this role in January 2023. Prior to joining Leerink Partners, Opal served as Principal Investments at Novo Holdings from January 2022 to December 2022. Her extensive experience includes roles such as Director of Business Development at TrialSpark (2020-2021) and Flatiron Health (2019-2020), as well as Commercial Investments, Business Development at Roivant Sciences (2018-2019). Earlier in her career, she was a Senior Associate at Palladium Equity Partners, LLC (2016-2018) and a Consultant at Deloitte Consulting (2010-2014). Opal's diverse background in investment and business development positions her as a key asset in her current role at Leerink Partners.